Prior murine studies in the treatment of cardiac dysfunction targeting Cx43 demonstrated reduced disease progression via enhancing Cx43 expression in Duchenne muscular dystrophy mice [130]. The gene discussed is GJA1; the disease is Duchenne muscular dystrophy.